Montpellier, France-based Quantum Surgical, a medical robotics company, announced that it has secured €30M loan from the European Investment Bank (EIB).
This investment benefits from the guarantee of the InvestEU program established by the European Commission. This is the second loan granted by the EIB to Quantum Surgical, following an initial financing in 2021 for the commercial launch of Epione.
The funding will help the French company accelerate the commercialisation of the medical robot Epione, designed for the minimally invasive treatment of abdominal and lung cancer.
The funding announcement comes a few weeks after Paoli-Calmettes Institute in Marseille acquired Epione last month.
Epione: What is it?
Epione enables interventional radiologists to perform safe and effective minimally invasive percutaneous tumour ablations by inserting one or more needles through the skin to destroy the tumour.
Epione is CE-marked in Europe for abdomen and lung tumors and FDA-cleared for abdominal tumors.
The Epione solution combines:
Multimodal Planning
- Fusion of CT and MRI images
- Enhance the visualisation of the tumour
Respiratory Monitoring
- Real-time respiration tracking
- Synchronisation of respiration
- for probe placement
Post-Ablation Treatment Confirmation
- Fusion of pre-and post-ablation images
- Verification of ablation margins
- after treatment
Robotic Guidance with Navigation & Haptics
- 6 degrees of freedom for unprecedented dexterity
- Universal needle guide
- Quick & safe needle release
Epione is available in France at the Gustave Roussy Cancer Center in Villejuif, at the Hospices Civils de Lyon, at the Paoli-Calmettes Institute in Marseille, and in Miami, United States.
More than 4 million new cases of abdominal and lung cancers are diagnosed each year worldwide. Several hundred patients have already been treated worldwide using Quantum Surgical’s medical platform.
“At Quantum Surgical, our goal is to provide patients with innovative and effective treatment on a global scale. We are delighted to receive support once again from the EIB. This demonstrates that our technology is destined for global adoption to revolutionize cancer treatment,” says Bertin Nahum, CEO and co-founder of Quantum Surgical.
Quantum Surgical : Interventional oncology robotics
Co-founded in 2017 by Bertin Nahum (CEO), Quantum Surgical combines robotics and AI for the curative and early treatment of cancers.
The company aims to dramatically ease multiple probe procedures, which will make the treatment of large tumors more predictable.
According to the company, its technology can help more patients benefit from innovative, better-targeted, and less invasive treatments.
Hundreds of patients have already been treated worldwide.
Currently, the company employs over 110 employees and has offices in Miami, Florida.
“Already a partner of Quantum Surgical, the EIB is pleased to support once again the development of a surgical robot that has proven its worth in the medical field. This €30 million financing demonstrates Europe’s commitment to supporting innovation and promising technologies in the healthcare sector, essential for improving the lives and well-being of patients on a much larger scale,” states Ambroise Fayolle, Vice President of the European Investment Bank.
01
Empowering Ukrainian Startups: Highlights from the PowerUp Ukraine 2024 Conference